Quinolone-resistant Salmonella typhi in Viet Nam: Molecular basis of resistance and clinical response to treatment

Clinical Infectious Diseases

Volumn 25, Issue 6, 1997, Pages 1404-1410

  Wain, John ^a   Hoa, Nguyen T T ^b   Chinh, Nguyen T ^b   Vinh, Ha ^b   Everett, Martin J ^b   Diep, To S ^a   Day, Nicholas P J ^b   Solomon, Tom ^b   White, Nicholas J ^b   Piddock, Laura J V ^b   Parry, Christopher M ^b  

^a Centre for Tropical Diseases Vietnam   (Viet Nam)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NALIDIXIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALMONELLA TYPHI; SINGLE STRAND CONFORMATION POLYMORPHISM; TYPHOID FEVER; VIET NAM;

EID: 18844482048     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516128     Document Type: Article

References (30)

1. Hien TT, Duong NM, Ha HD, et al. A randomized comparative study of fleroxacin and ceftriaxone in enteric fever. Trans R Soc Trop Med Hyg 1994;88:464-5.
2. Smith MD, Duong NM, Hoa NTT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994;38:1716-20.
3. Hien TT, Bethell DB, Hoa NTT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995;20:917-23.
4. Duong NM, Chau NVV, Anh DCV, et al. Short course ofloxacin in the treatment of typhoid fever. JAMA (Southeast Asia) 1995;11:21-5.
5. Vinh H, Wain J, Hanh VTN, et al. Two or three days of ofloxacin treatment for uncomplicated multi-drug resistant typhoid fever in children. Antimicrob Agents Chemother 1996;40:958-61.
6. Bethell DB, Hien TT, Phi LT, et al. Effects on growth of single short courses of fluoroquinolones. Arch Dis Child 1996;74:44-6.
7. Piddock LJV. Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994. Drugs 1995;49(suppl 2):29-35.
8. Brown JC, Thomson CJ, Amyes SGB. Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs. J Antimicrob Chemother 1996;37:351-6.
9. Griggs DJ, Gensberg K, Piddock LJV. Mutations in the gyrA gene of quinolone-resistant salmonella serotypes isolated from man and animals. Antimicrob Agents Chemother 1996;40:1009-13.
10. Reyna F, Huesca M, Gonzalez VX, Fuchs LY. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob Agents Chemother 1995;39:1621-3.
11. Piddock LJV, Griggs DJ, Hall MC, Jin YF. Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob Agents Chemother 1993;37:662-6.
12. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
13. Tokue Y, Sugano K, Saito D, et al. Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing. Antimicrob Agents Chemother 1994;38:428-31.
14. Takiff HE, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994;38:773-80.
15. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
16. Chinh NT, Solomon T, Thong MX, et al. Short courses of ofloxacin for the treatment of enteric fever. Trans R Soc Trop Med Hyg 1997;91:347-9.
17. Faiers M, George R, Jolly J, Wheat P. Multipoint methods in the clinical laboratory: a handbook. London: Public Health Laboratory Service, 1991.
18. Ausubel FM, Brent R, Kingston RE, et al. Current protocols in molecular biology. New York: John Wiley and Sons, 1996.
19. Mehta A, Rodriques C, Joshi VR. Multiresistant Salmonella organisms in India [letter]. JAMA 1992;267:1614.
20. Umasankar S, Wall RA, Berger J. A case of ciprofloxacin-resistant typhoid fever. Commun Dis Rep CDR Rev 1992;2:R139-40.
21. Chandra R, Srinivasan S, Nalini P, Rao S. Multidrug resistant enteric fever. J Trop Med Hyg 1992;95:284-7.
22. Biswal N, Mathai B, Bhatia BD, Srinivasan S. Use of ciprofloxacin and its resistance in typhoid fever [letter]. Indian Pediatr 1994;31:229-30.
23. Daga MK, Sarin K, Sarkar R. A study of culture positive multidrug resistant enteric fever - changing pattern and emerging resistance to ciprofloxacin. J Assoc Physicians India 1994;42:599-600.
24. Rowe B, Ward LR, Threlfall EJ. Ciprofloxacin-resistant Salmonella typhi in the UK [letter]. Lancet 1995;346:1302.
25. Hoa NTT, Phi LT, Hien TT, et al. Antibiotic resistance in Salmonella typhi and Salmonella paratyphi A from Viet Nam [abstract no WeP3-2]. In: 13th Congress for Tropical Medicine and Malaria (Pataya, Thailand). 1996:P193.
26. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, NCCLS document M7-A. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1985.
27. Brown JC, Shanahan PMA, Jesudason MV Thomson CV, Amyes SGB. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-drug resistant Salmonella typhi in India. J Antimicrob Chemother 1996;37:891-900.
28. Truong QC, Ouabdesselam S, Hooper DC, Moreau NJ, Soussy CJ. Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy. J Antimicrob Chemother 1995;36:1055-9.
29. Bethell DB, Day NP-J, Dung NM, et al. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Antimicrob Agents Chemother 1996;40:2167-72.
30. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Rev Infect Dis 1986;8:329-49.